韩国前列腺癌:2011-2021年期间全国流行率和药物使用趋势
Jaehee Jung1, Hyunha Kang2, Eunjung Choo3
1College of Pharmacy, Yonsei Institute of Pharmaceutical Science, Yonsei University, Incheon, Republic of Korea.
Cancer epidemiology
|January 17, 2026
概括
韩国前列腺癌 (PC) 发病率从2011年至2021年期间升了170% . 虽然雄激素剥夺疗法仍然很常见,但新的雄激素受体向药物越来越多地使用,反映了不断变化的PC治疗模式.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 药理学 药理学 是一个学科.
背景情况:
- 全球前列腺癌 (PC) 发病率正在上升,特别是随着人口老龄化.
- 针对雄激素受体的药物的进步正在改变PC治疗策略.
- 了解韩国PC流行病学和药物利用对于调整护理至关重要.
研究的目的:
- 分析2011年至2021年韩国前列腺癌的流行病学趋势.
- 为了研究前列腺癌治疗模式和药物使用在十年中的变化.
- 提供有关韩国前列腺癌当前临床情况的真实数据.
主要方法:
- 采用了基于患病率的横截面研究设计.
- 数据涵盖了2011年至2021年期间接受PC医疗护理的所有韩国患者.
- 分析包括患者的人口统计,并发病,转移状态和药理疗法.
主要成果:
- 从2011年到2021年,PC患病率增加了170.45% (每10万男性220到532).
- PC患者的平均年龄为73.07岁,超过80%的患者年龄在65岁以上.
- 由于受体向药物的利用率增加,雄激素剥夺治疗的使用率下降.
结论:
- 这项研究为韩国前列腺癌流行病学提供了现实世界的见解.
- 治疗模式显示,与既定疗法一起,新药正在转向新药.
- 这些发现增强了对韩国前列腺癌不断发展的临床管理的理解.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


